Упрощенная HTML-версия
120
107.
Isomaa B. Cardiovascular morbidity and mortality consists with
metabolic syndrome / B. Isomaa, K. Lahti, P. Almgren et al. // Diab. Car. – 2001.
– V.24. – P. 683-689.
108.
Johnstone M.T. Impaired endothelium-dependent vasodilation in pa-
tients with insulin-dependent diabetes mellitus / M.T. Johnstone, S.L. Creager,
K.M. Scales et al. // Circulation. – 1993. – V. 88. – P. 2510-2516.
109.
Joint Recommendations of the British Cardiac Society, British Hy-
perlipidemia Association, British Diabetic Association on Prevention of Coronary
Heart Disease in Clinical Practice // Heart. – 1998. – V.80. – Suppl.2. – P.1-28.
110. Kannel W.B. Electrocardiographic left ventricular hypertrophy and
risk of coronary heart disease. The Framingham Study / W.B. Kannel, T. Gordon,
J.R. Margolis // Ann Intern Med. – 1970. – V.72. – P. 813-822.
111. Kannel W.B. A general cardiovascular risk profile: The Framingham
study / W.B. Kannel, D. Mc Gree, T.A. Gordon // Am J Cardiol. – 1976. – V.38.
– P. 46-51.
112. Kannel W.B. The clinical heterogenity of hypertension / W.B. Kan-
nel // Am J Hypertension. – 1991. – V. 4. – P. 283-287.
113. Kaplan K.L. Plasma levels of beta-thrombomodulin of captopril on
platelet aggregation in vivo / K.L. Kaplan, L. Owen // Blood. – 1981. – V. 57. –
P. 199-202.
114. Kaplan N.M. The deadly quartet: upper body obesity, glucose intol-
erance, hypertriglyceridemia, and hypertention / N.M. Kaplan // Arch Int Med. –
1989. – V.149. – P. 1514-1520.
115. Katakam P.V. Endothelial dysfunction precedes hypertension in diet
induced insulin resistence / P.V. Katakam, M.R. Ujhelyi, M.E. Hoenig et al. //
Am J Physiol. – 1998. – V. 275. – P.788-792.
116. Keys A. Seven countries: a multivariate analysis of death and coro-
nary heart disease / A. Keys // Cambridge (Massachusetts): Harvard University
Press 1980. 381 p.